These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17409581)

  • 1. Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure.
    Sasaki S; Niwano S; Fukaya H; Yuge M; Imaki R; Inomata T; Izumi T
    Int Heart J; 2007 Mar; 48(2):155-63. PubMed ID: 17409581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
    J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure.
    Niwano S; Fukaya H; Yuge M; Imaki R; Hirasawa S; Sasaki T; Yumoto Y; Inomata T; Izumi T
    Circ J; 2008 Feb; 72(2):268-73. PubMed ID: 18219165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial.
    Senges JC; Becker R; Schreiner KD; Bauer A; Weretka S; Siegler K; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):183-90. PubMed ID: 11915985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.
    Zaman S; Sivagangabalan G; Chik W; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    J Interv Card Electrophysiol; 2014 Dec; 41(3):195-202. PubMed ID: 25267274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy.
    Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Zhou X; Gunderson BD; Olson WH;
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):14-20. PubMed ID: 15028067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
    J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
    Yuge M; Niwano S; Moriguchi M; Sasaki T; Hirasawa S; Imaki R; Sato D; Izumi T
    Circ J; 2006 Mar; 70(3):268-72. PubMed ID: 16501291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.